Artificial Intelligence (AI) Pathology Quality Control Market Report 2026

Artificial Intelligence (AI) Pathology Quality Control Market Overview

• Artificial Intelligence (AI) Pathology Quality Control market size has reached to $1.78 billion in 2025 • Expected to grow to $4.65 billion in 2030 at a compound annual growth rate (CAGR) of 21.1% • Growth Driver: Increasing Demand For Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomics And Tailored Treatments • Market Trend: Advanced Technology Improves Digital Pathology Workflow • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI) Pathology Quality Control Market?

Artificial intelligence (AI) pathology quality control refers to the use of AI algorithms and machine learning models to automatically assess and ensure the accuracy, consistency, and reliability of pathology data and slide interpretations. Its primary purpose is to detect errors, standardize analysis, and enhance diagnostic precision in histopathology and cytopathology workflows, ultimately improving patient outcomes. The primary components of artificial intelligence (AI) pathology quality control are software, hardware, and services. Software refers to artificial intelligence-driven platforms and applications designed for automated analysis, quality assessment, and error detection in pathology workflows. It can be deployed through cloud-based and on-premises modes. It finds applications in cancer diagnostics, infectious disease diagnostics, digital pathology, research, and others, serving key end-users such as hospitals, diagnostic laboratories, research institutes, pharmaceutical and biotechnology companies, and others.

What Is The Artificial Intelligence (AI) Pathology Quality Control Market Growth Forecast?

The artificial intelligence (ai) pathology quality control market size is expected to see exponential growth in the next few years. It will grow to $4.65 billion in 2030 at a compound annual growth rate (CAGR) of 21.1%. The growth in the forecast period can be attributed to increasing investments in digital pathology platforms, rising demand for precision diagnostics, expansion of ai validation in clinical workflows, growing integration of pathology data analytics, increasing regulatory emphasis on diagnostic quality control. Major trends in the forecast period include increasing deployment of AI-based slide quality assessment, rising adoption of automated error detection tools, growing standardization of pathology workflows, expansion of digital pathology integration, enhanced focus on diagnostic accuracy assurance.

Global Artificial Intelligence (AI) Pathology Quality Control Market Segmentation

1) By Component: Software, Hardware, Services 2) By Deployment Mode: On-Premises, Cloud-Based 3) By Application: Cancer Diagnostics, Infectious Disease Diagnostics, Digital Pathology, Research, Other Applications 4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users Subsegments: 1) By Software: Image Analysis Software, Diagnostic Decision Support Software, Workflow Management Software, Reporting And Visualization Software 2) By Hardware: Digital Pathology Scanners, Imaging Devices, Servers And Storage Systems, Laboratory Equipment 3) By Services: Implementation Services, Training And Support Services, Maintenance And Upgrade Services, Consulting Services

What Is The Driver Of The Artificial Intelligence (AI) Pathology Quality Control Market?

The increasing demand for personalized medicine is expected to propel the growth of the artificial intelligence (AI) pathology quality control market going forward. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to an individual’s unique genetic makeup, lifestyle, and environment. The increasing adoption of personalized medicine is primarily due to advancements in genomics, which enable precise identification of genetic variations and tailored treatments for individuals. Artificial intelligence (AI) pathology quality control enhances personalized medicine by delivering precise and consistent diagnostic insights, enabling tailored treatment strategies. It reduces diagnostic errors by automating quality checks, improving accuracy and reliability, and ultimately advancing patient-specific care. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the increasing demand for personalized medicine will drive the artificial intelligence (AI) pathology quality control industry.

Key Players In The Global Artificial Intelligence (AI) Pathology Quality Control Market

Major companies operating in the artificial intelligence (AI) pathology quality control market are Roche Diagnostics GmbH, Danaher Corporation, Philips Healthcare, Agilent Technologies Inc., Hologic Inc., Clinisys Group Ltd., Sectra AB, PathAI Inc., OptraSCAN Inc., Paige.AI Inc., Proscia Inc., Quibim S.L., 3DHISTECH Ltd., Visiopharm A/S, Indica Labs Inc., Ibex Medical Analytics Ltd., Aiosyn B.V., DeepBio Inc., Nucleai Ltd., Gestalt Diagnostics LLC

Global Artificial Intelligence (AI) Pathology Quality Control Market Trends and Insights

Major companies operating in the artificial intelligence (AI) pathology quality control market are focusing on developing advanced solutions, such as advanced AI-powered solutions to enhance diagnostic accuracy, streamline laboratory workflows, and ensure the reliability of pathology data. Advanced AI-powered solutions refer to next-generation technologies that use artificial intelligence to perform complex tasks with greater accuracy, speed, and efficiency. For instance, in November 2023, PathAI, a US-based biotechnology company, launched Artifact Detect 1 on its AISight digital pathology platform. The tool automates the detection and quantification of artifacts in whole slide images (WSI), which are non-relevant morphological features that can compromise diagnostic accuracy. ArtifactDetect minimizes misdiagnosis and rescans by automatically pre-screening slides for quality issues, enhancing accuracy, laboratory efficiency, and overall throughput. This innovation supports timely corrective actions such as re-staining or re-scanning, ultimately improving digital workflow and conserving resources for technicians and pathologists.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI) Pathology Quality Control Market?

In November 2024, Molbio Diagnostics Pvt. Ltd., an India-based molecular diagnostics company, acquired a majority stake in OptraSCAN Inc. through a $30 million investment. With this acquisition, Molbio aims to strengthen its presence in digital and AI-driven pathology, expand its diagnostic portfolio beyond molecular testing, enhance global market reach, and accelerate innovation in pathology quality control and precision diagnostics. OptraSCAN Inc. is a US-based company that provides artificial intelligence (AI) solutions for pathology quality control as part of its digital pathology offerings.

Regional Outlook

North America was the largest region in the artificial intelligence (AI) pathology quality control market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence (AI) Pathology Quality Control Market?

The artificial intelligence (AI) pathology quality control market consists of revenues earned by entities by providing services such as automated slide review, error detection in pathology reports, consistency checks in histopathology and cytopathology analyses, digital image analysis, workflow optimization, and validation of diagnostic results using AI-powered tools. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) pathology quality control market also includes sales of artificial intelligence (AI)-powered pathology software, digital pathology platforms, image analysis tools, and quality assurance modules. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence (AI) Pathology Quality Control Market Report 2026?

The artificial intelligence (ai) pathology quality control market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai) pathology quality control industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.